Progressive MS, young investigators, and more from New Orleans for the 2016 ACTRIMS Forum
The MS Society’s research team is in the beautiful and historic city of New Orleans for the 2016 Americas Committee for Treatment and…
Research Decoder: Translational Research
“Translational research” is a popular term these days, with special relevance for the fields of science and technology. While the process of translational…
Jonathan Allenger: Why I Ride
It’s the start of summer 2013, and Ottawa-born Jonathan Allenger, 32 years old and working in the Canadian finance industry is sitting in…
Meet the original members of #TeamFight
Throughout history, women have fought for rights, freedom and power. We are fighters, and we know how to take action to effect change…
199 new MPs need to know about MS
Today we are calling on you to make sure all elected Members of Parliament are aware of what’s needed for Canadians affected by…
Annual Research Competition reviews wrap up
The review meetings for the Multiple Sclerosis Society’s Annual Research Competition took place last week, with the research department firing on all cylinders…
MS Research Year in Review: 2015
The year 2015 marked the 20th anniversary of the approval of the Advancements in the last two decades have led to faster diagnoses, better…
Happy Holidays from the MS Society research team!
As the end of 2015 draws near, I can’t help but feel a sense of hope and pride as I reflect upon what…
Vitamin D and MS: What we’ve learned over the past year
It’s been over a year since my last major update on vitamin D in which I summarized highlights from the Vitamin D Consensus…
What is MS?
Canada has one of the highest rates of multiple sclerosis (MS) in the world, with an estimated 77,000 Canadians living with the disease. While it is most often diagnosed in young adults aged 20 to 49, younger children and older adults are also diagnosed with the disease.